Marijuana DUI: Legal Standards and Per Se Limits by State
Marijuana DUI prosecutions occupy a distinct and contested space within drugged driving laws because cannabis impairment cannot be measured with the same reliability as alcohol intoxication. Unlike the 0.08% blood alcohol concentration standard that governs alcohol-based DUI charges nationally, marijuana THC thresholds vary sharply across states — and a subset of states impose no numeric threshold at all. This page covers the classification of marijuana DUI laws, the testing and evidentiary mechanisms used to establish impairment, common enforcement scenarios, and the legal thresholds that determine how a case is charged.
Definition and scope
A marijuana DUI charge arises when a driver operates a motor vehicle while impaired by tetrahydrocannabinol (THC), the primary psychoactive compound in cannabis, or by cannabis metabolites. The charge falls under the broader framework of impaired driving statutes, which in every U.S. jurisdiction prohibit operating a vehicle while one's ability to do so is materially affected by any intoxicating substance.
The legal complexity stems from the pharmacokinetics of THC. Unlike ethanol, which correlates reasonably well between blood concentration and functional impairment, THC does not. THC is fat-soluble and can persist in blood and urine for days or weeks after the acute effects of cannabis have resolved — a dynamic documented in regulatory sources and acknowledged by the National Highway Traffic Safety Administration (NHTSA) in its drug-impaired driving research. This creates an evidentiary problem: a positive THC blood test does not necessarily establish that a driver was impaired at the time of the stop.
States have responded with 3 distinct legal frameworks:
- Per se THC limits — A specific nanogram-per-milliliter (ng/mL) threshold in blood triggers automatic impairment as a matter of law, regardless of observed behavior.
- Zero tolerance — Any detectable THC or metabolite in blood or urine constitutes a per se violation, with no minimum concentration required.
- Effect-based (behavioral) standards — No numeric THC threshold exists; the prosecution must prove the driver was actually impaired by observable evidence such as field sobriety test performance, driving behavior, and officer testimony.
How it works
Testing mechanisms
Law enforcement investigating a suspected marijuana DUI typically follows a structured progression. Because a breathalyzer test does not reliably detect THC, officers primarily rely on:
- Field Sobriety Tests (FSTs) — Standardized tests such as the Walk-and-Turn and One-Leg-Stand, validated by NHTSA for alcohol, but whose predictive validity for cannabis impairment has been questioned by the National Institute on Drug Abuse (NIDA).
- Drug Recognition Expert (DRE) evaluation — A 12-step protocol developed by the International Association of Chiefs of Police (IACP) and adopted by NHTSA. A certified DRE evaluates physiological indicators including pupil dilation, muscle tone, vital signs, and behavioral markers to form an opinion on the category of drug causing impairment.
- Blood draw — A blood test measures active THC (delta-9-THC), THC-COOH (a non-psychoactive metabolite), and 11-hydroxy-THC. Admissibility standards for blood draws, including chain-of-custody requirements and laboratory certification, vary by state but generally follow protocols aligned with state forensic standards boards.
Drivers who refuse a blood draw may face consequences under implied consent laws, which in most states attach automatic license suspension penalties independent of the underlying DUI charge.
Per se threshold states
Five states — Colorado, Montana, Nevada, Ohio, and Washington — have enacted statutory per se THC limits. Colorado and Washington set the threshold at 5 ng/mL of delta-9-THC in whole blood (Colorado Revised Statutes § 42-4-1301; Washington RCW 46.61.502). Nevada's per se limit is 2 ng/mL of THC (Nevada Revised Statutes § 484C.110). Ohio applies a 2 ng/mL limit as well.
Zero tolerance states
A subset of states — including Arizona, Delaware, Georgia, Indiana, Iowa, Michigan, Rhode Island, and Utah — apply zero tolerance for THC or metabolites in blood, meaning any positive result establishes the chemical element of the offense (Arizona Revised Statutes § 28-1381). Arizona's statute explicitly includes THC metabolites, which has generated significant litigation given that metabolites can appear in blood weeks after cannabis use.
Effect-based states
The majority of states use effect-based or behavioral impairment standards with no per se THC threshold. California, Florida, Texas, Illinois, and New York are among the effect-based jurisdictions. Under this model, the DUI laws by state framework requires the prosecution to establish actual impairment through the totality of evidence rather than a blood number alone.
Common scenarios
Scenario 1: Medical cannabis patient, per se state. A patient using cannabis under a state medical program may have residual THC in blood from prior therapeutic use that exceeds the 5 ng/mL per se threshold even if not currently impaired. In a per se jurisdiction, the blood result alone may satisfy the statutory element of impairment.
Scenario 2: Recent recreational use, effect-based state. A driver stopped for a lane departure who smoked cannabis two hours earlier may test positive for THC but display minimal impairment on FSTs. In an effect-based state, the outcome hinges on officer testimony, DRE evaluation, and driving behavior — not the blood concentration.
Scenario 3: Metabolite-only positive, zero tolerance state. A driver whose blood shows only THC-COOH (the non-psychoactive metabolite, not active THC) may nonetheless face a per se violation in Arizona and other zero tolerance states that include metabolites in their statutory language. Constitutional challenges to this application have reached state appellate courts with mixed outcomes.
Scenario 4: Combined alcohol and marijuana. Polydrug impairment cases — where both alcohol and THC are detected — may result in charges under both the BAC standard (see DUI blood alcohol concentration limits) and the marijuana impairment standard, potentially affecting sentencing guidelines and plea options.
Decision boundaries
The threshold questions that determine how a marijuana DUI is classified and charged include the following:
- Jurisdiction type. Per se, zero tolerance, and effect-based frameworks impose different evidentiary burdens on the prosecution and different defense postures.
- Compound detected. Active delta-9-THC versus metabolite-only results carry different legal weight depending on the applicable statute.
- Concentration level in per se states. In Colorado and Washington, a reading at or above 5 ng/mL of whole blood THC creates a permissive inference of impairment that the defense may rebut — it is not a conclusive presumption. This distinguishes marijuana per se law from the stricter alcohol per se standard.
- DRE certification and protocol adherence. Courts have scrutinized DRE testimony under Daubert and Frye evidentiary standards. Admission of DRE opinion evidence is not uniform; jurisdictions including California have found DRE testimony admissible while others have placed limits on the scope of that testimony.
- Felony versus misdemeanor classification. Most first-offense marijuana DUIs are misdemeanors, but aggravating factors — including injury, a minor passenger, or prior DUI convictions — can elevate the charge. The felony vs. misdemeanor DUI distinction affects available diversion options and long-term record consequences.
- Federal employment or commercial driving nexus. Commercial drivers face a 0.0% tolerance for THC under federal Department of Transportation regulations (49 CFR Part 382), separate from state criminal thresholds. A state-level marijuana DUI conviction can trigger commercial driver DUI disqualification independent of the criminal disposition.
References
- National Highway Traffic Safety Administration — Drug-Impaired Driving
- National Institute on Drug Abuse — Drugged Driving
- International Association of Chiefs of Police — Drug Evaluation and Classification Program
- Colorado Revised Statutes § 42-4-1301
- Washington RCW 46.61.502
- Nevada Revised Statutes § 484C.110
- [Arizona Revised Statutes § 28-1381](https://www.azleg.gov/ars/28/01381.